Inpatient Versus Outpatient Foley Cervical Ripening Study

February 21, 2023 updated by: Yale University
To compare the efficacy and safety of cervical ripening with transcervical Foley catheter in inpatient vs outpatient setting

Study Overview

Status

Completed

Conditions

Detailed Description

The aim of the current study is to compare the efficacy and safety of cervical ripening with transcervical Foley catheter in inpatient vs outpatient setting in a diverse, urban population within the United States. We hypothesize that there will be no differences in time-to-delivery, failed induction rates, cesarean section rates, or maternal/neonatal morbidity and that there will be no differences in total length of stay (LOS), hours of sleep, active labor duration, and perceived satisfaction between groups.

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Connecticut
      • New Haven, Connecticut, United States, 06520
        • Yale New Haven Hospital, York Street Campus
      • New Haven, Connecticut, United States, 06511
        • Yale New Haven Hospital- St. Raphael

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Indication for Induction of Labor is present
  • Gestational age > 37 completed weeks with absence of comorbidities with an optimal dating (ultrasonography was performed before 22 weeks gestation)
  • Singleton fetus in cephalic presentation confirmed with an ultrasound at the time of presentation for induction of labor
  • Cervical exam with Bishop Score <6
  • Intact membranes
  • Normal vital signs (blood pressure < 140/90, normal body temperature) at the time of presentation for Induction of Labor and within the last 24 hours
  • Maternal age ≥18 years of age

Exclusion Criteria:

  • Any contraindication for vaginal birth by institutional policy
  • Multiple gestation
  • History of cesarean delivery
  • Oligohydramnios/polyhydramnios/anhydramnios (MVP <2cm)
  • Rupture of membranes
  • Poorly controlled diabetes (Hgb A1C>8% and/or fingerstick glucose above target >50% of the time in the past week)
  • Poorly controlled chronic hypertension, gestational hypertension or preeclampsia (patient requiring IV antihypertensives within 4 hours of arrival)
  • Vaginal bleeding
  • Any conditions that require continuous electronic fetal monitoring either by institutional policy or provider determination (intrahepatic cholestasis of pregnancy, intrauterine growth restriction, abnormal non-stress test, others)
  • Fetal anomaly with anticipated neonatal intensive care unit admission
  • Fetal demise
  • HIV infection, presence of genital herpetic lesion
  • History of substance abuse during this pregnancy
  • History of precipitous delivery (delivery <3hrs from onset of labor)
  • Poor access to care (social, distance to hospital > 45 min, limited transportation)
  • Poor social situation, history of domestic violence, untreated/uncontrolled psychiatric condition
  • Inability to give informed consent, history of mental retardation
  • Strong preference for inpatient management
  • Inability to understand English or Spanish

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Outpatients with a transcervical Foley catheter
Women with a transcervical Foley catheter in place that will spend the night at home.
The offered (studied) intervention will be allowing the women with a transcervical Foley catheter in place to spend the night at home.
Active Comparator: Inpatients with a transcervical Foley catheter
Women to be admitted to the hospital overnight which has been a "standard of care".
Women with a transcervical Foley catheter to be admitted to the hospital overnight which has been a "standard of care".

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time of Foley catheter extrusion
Time Frame: within 24 hours
Antepartum time of Foley catheter extrusion before patient being brought to labor
within 24 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bishop score
Time Frame: during labor
Bishop scoring system used to consider having cervical ripening.Women with favorable cervices (BS 8 or more) are considered to have a cervix ripe and ready to proceed to induction. BS <6 are considered unripe, and therefore may benefit from additional ripening modalities
during labor
Total time in cervical ripening
Time Frame: from labor induction to delivery time
Measure of total time in cervical ripening
from labor induction to delivery time
Total time slept during pre-induction
Time Frame: during labor
Total time slept during pre-induction
during labor
Total time in hospital
Time Frame: no max but an average of 3 days
Total time in hospital
no max but an average of 3 days
Analgesia used during pre-induction
Time Frame: within 24 hours before Pitocin initiation
Analgesia used during pre-induction
within 24 hours before Pitocin initiation
Use of oxytocin
Time Frame: 3 days
Pitocin is given as a continuous infusion and the dose is titrated according to the contraction pattern (goal max contractions but not hyperstimulation). We will calculate the total time of Pitocin infusion as well as total dose (rate of infusion x time).
3 days
Fever over 38 degrees C
Time Frame: within 7 days of Foley placement
Did the patient have a fever over 38 degrees C
within 7 days of Foley placement
Neonatal Intensive Care Unit (NICU)
Time Frame: within 7 days of Foley placement
Was the baby admitted to NICU
within 7 days of Foley placement
APGAR scores
Time Frame: 1 minute of life
Apgar score is a universal (international) scoring system. The 1-minute score determines how well the baby tolerated the birthing process. The 5-minute score tells the health care provider how well the baby is doing outside the mother's womb.
1 minute of life
APGAR scores
Time Frame: 5 minutes of life
Apgar score is a universal (international) scoring system. The 1-minute score determines how well the baby tolerated the birthing process. The 5-minute score tells the health care provider how well the baby is doing outside the mother's womb.
5 minutes of life
Hospital charges
Time Frame: within 30 days after discharge
All patients will be charged. We are hoping to see lower charges for women in the Out Patient group.
within 30 days after discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Katherine Kohari, MD, Yale University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 8, 2019

Primary Completion (Actual)

June 27, 2022

Study Completion (Actual)

June 27, 2022

Study Registration Dates

First Submitted

June 22, 2018

First Submitted That Met QC Criteria

October 29, 2018

First Posted (Actual)

October 31, 2018

Study Record Updates

Last Update Posted (Estimate)

February 22, 2023

Last Update Submitted That Met QC Criteria

February 21, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2000022710

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Induced; Birth

Clinical Trials on Outpatient

3
Subscribe